Dithiocarbamate propineb induces acetylcholine release through cytoskeletal actin depolymerization in PC12 cells

2008 ◽  
Vol 182 (1-3) ◽  
pp. 63-68 ◽  
Author(s):  
B VIVIANI ◽  
S BARTESAGHI ◽  
M BINAGLIA ◽  
E CORSINI ◽  
M BORASO ◽  
...  
2003 ◽  
Vol 144 ◽  
pp. s146-s147
Author(s):  
S. Bartesaghi ◽  
M. Binaglia ◽  
B. Viviani ◽  
Corrado L. Galli ◽  
M. Marinovich

2012 ◽  
Vol 21 (1) ◽  
pp. 15-21
Author(s):  
Merete Bakke ◽  
Allan Bardow ◽  
Eigild Møller

Severe drooling is associated with discomfort and psychosocial problems and may constitute a health risk. A variety of different surgical and non-surgical treatments have been used to diminish drooling, some of them with little or uncertain effect and others more effective but irreversible or with side effects. Based on clinical evidence, injection with botulinum toxin (BTX) into the parotid and submandibular glands is a useful treatment option, because it is local, reversible, and with few side effects, although it has to be repeated. The mechanism of BTX is a local inhibition of acetylcholine release, which diminishes receptor-coupled secretion and results in a flow rate reduction of 25–50% for 2–7 months.


2006 ◽  
Vol 114 (S 1) ◽  
Author(s):  
CG Ziegler ◽  
AW Krug ◽  
F Sicard ◽  
S Sperber ◽  
M Ehrhart-Bornstein ◽  
...  

2007 ◽  
Vol 40 (05) ◽  
Author(s):  
K Leuner ◽  
M Müller ◽  
V Kasanzki ◽  
C Harteneck ◽  
WE Müller
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document